Sin embargo, normalmente recomendamos volver para una segunda cita de seguimiento para garantizar que los resultados sean duraderos
Your provider can help you weigh the benefits and risks of continuing versus discontinuing treatment, considering your individual health goals, risk factors, and preferences
To see what change actually looks like, read GHK-Cu before and after: what the research shows
To investigate the relative contribution of non-genetic factors that predict GLP1 medication efficacy, we fit a linear model to assess the combined effect of age, sex, pre-treatment BMI, drug type, drug dose and time on drug on total BMI loss (Supplementary Table 3)
It is primarily investigated for its role in satiety signaling, food intake regulation, and metabolic homeostasis pathways